Estrogen receptor promoter methylation predicts survival in low-grade ovarian carcinoma patients.
Kirn V, Shi R, Heublein S, Knabl J, Guenthner-Biller M, Andergassen U, Fridrich C, Malter W, Harder J, Friese K, Mayr D, Jeschke U.
Kirn V, et al.
J Cancer Res Clin Oncol. 2014 Oct;140(10):1681-7. doi: 10.1007/s00432-014-1729-9. Epub 2014 Jun 8.
J Cancer Res Clin Oncol. 2014.
PMID: 24908329